These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 22983587
1. Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research. Keating A, DaSilva G, Pérez WS, Gupta V, Cutler CS, Ballen KK, Cairo MS, Camitta BM, Champlin RE, Gajewski JL, Lazarus HM, Lill M, Marks DI, Nabhan C, Schiller GJ, Socie G, Szer J, Tallman MS, Weisdorf DJ. Haematologica; 2013 Feb; 98(2):185-92. PubMed ID: 22983587 [Abstract] [Full Text] [Related]
2. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, Blaise D, Arcese W, Sociè G, Bourhis JH, Van Lint MT, Bruno B, Huynh A, Santarone S, Deconinck E, Mohty M, Nagler A. Haematologica; 2018 Aug; 103(8):1317-1328. PubMed ID: 29748438 [Abstract] [Full Text] [Related]
3. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis. Novitzky N, Thomas V, du Toit C, McDonald A. Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030 [Abstract] [Full Text] [Related]
9. Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT. Saraceni F, Labopin M, Gorin NC, Blaise D, Tabrizi R, Volin L, Cornelissen J, Cahn JY, Chevallier P, Craddock C, Wu D, Huynh A, Arcese W, Mohty M, Nagler A, Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT). J Hematol Oncol; 2016 Sep 02; 9(1):79. PubMed ID: 27589849 [Abstract] [Full Text] [Related]
10. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Busca A, Anasetti C, Anderson G, Appelbaum FR, Buckner CD, Doney K, Martin PJ, Petersdorf E, Sanders JE, Hansen JA. Blood; 1994 May 15; 83(10):3077-84. PubMed ID: 8180404 [Abstract] [Full Text] [Related]
12. HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia. Herr AL, Labopin M, Blaise D, Milpied N, Potter M, Michallet M, Heit W, Ferrara F, Esteve J, Arcese W, Ehninger G, Rowe JM, Kobbe G, Rosselet A, Bunjes D, Rio B, Brune M, Nagler A, Gorin NC, Frassoni F, Rocha V, Acute Leukemia Working Party or the European Group for Blood and Marrow Transplantation. Leukemia; 2007 Jan 15; 21(1):129-35. PubMed ID: 17128198 [Abstract] [Full Text] [Related]
13. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study. Klusmann JH, Reinhardt D, Zimmermann M, Kremens B, Vormoor J, Dworzak M, Creutzig U, Klingebiel T. Haematologica; 2012 Jan 15; 97(1):21-9. PubMed ID: 21933851 [Abstract] [Full Text] [Related]
15. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Nagler A, Labopin M, Beelen D, Ciceri F, Volin L, Shimoni A, Foá R, Milpied N, Peccatori J, Polge E, Mailhol A, Mohty M, Savani BN. Cancer; 2017 Jul 15; 123(14):2671-2679. PubMed ID: 28329410 [Abstract] [Full Text] [Related]
16. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia. Fan Q, Liu H, Liang X, Yang T, Fan Z, Huang F, Ling Y, Liao X, Xuan L, Xu N, Xu X, Ye J, Liu Q. J Hematol Oncol; 2017 Jul 04; 10(1):135. PubMed ID: 28676100 [Abstract] [Full Text] [Related]
17. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G. N Engl J Med; 1995 Jan 26; 332(4):217-23. PubMed ID: 7808487 [Abstract] [Full Text] [Related]
20. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A. Blood; 2000 Jun 15; 95(12):3702-9. PubMed ID: 10845900 [Abstract] [Full Text] [Related] Page: [Next] [New Search]